These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35249246)

  • 1. Zona pellucida glycoproteins: Relevance in fertility and development of contraceptive vaccines.
    Gupta SK
    Am J Reprod Immunol; 2023 Feb; 89(2):e13535. PubMed ID: 35249246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraceptive vaccines based on the zona pellucida glycoproteins for dogs and other wildlife population management.
    Gupta SK; Srinivasan VA; Suman P; Rajan S; Nagendrakumar SB; Gupta N; Shrestha A; Joshi P; Panda AK
    Am J Reprod Immunol; 2011 Jul; 66(1):51-62. PubMed ID: 21501280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zona pellucida-based contraceptive vaccines for human and animal utility.
    Gupta SK; Gupta N; Suman P; Choudhury S; Prakash K; Gupta T; Sriraman R; Nagendrakumar SB; Srinivasan VA
    J Reprod Immunol; 2011 Mar; 88(2):240-6. PubMed ID: 21377213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zona pellucida glycoproteins based immunocontraceptive vaccines: strategies for development and their applications.
    Gupta SK; Choudhury S; Srivastava N; Ravi C
    Indian J Exp Biol; 2003 Jul; 41(7):682-93. PubMed ID: 15255371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine.
    Gupta SK; Jethanandani P; Afzalpurkar A; Kaul R; Santhanam R
    Hum Reprod Update; 1997; 3(4):311-24. PubMed ID: 9459277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and challenges in the development of immunocontraceptive vaccine based on zona pellucida glycoproteins.
    Choudhury S; Srivastava N; Narwal PS; Rath A; Jaiswal S; Gupta SK
    Soc Reprod Fertil Suppl; 2007; 63():479-93. PubMed ID: 17566293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on zona pellucida glycoproteins based contraceptive vaccine.
    Gupta SK; Srivastava N; Choudhury S; Rath A; Sivapurapu N; Gahlay GK; Batra D
    J Reprod Immunol; 2004 Jun; 62(1-2):79-89. PubMed ID: 15288184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for designing an immunocontraceptive vaccine based on zona pellucida synthetic peptides and recombinant antigen.
    Kaul R; Afzalpurkar A; Gupta SK
    J Reprod Fertil Suppl; 1996; 50():127-34. PubMed ID: 8984175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats.
    Eade JA; Roberston ID; James CM
    Reproduction; 2009 Jun; 137(6):913-22. PubMed ID: 19279201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of autoimmune ovarian disease pathogenesis on ZP3 contraceptive vaccine design.
    Lou YH; Bagavant H; Ang J; McElveen MF; Thai H; Tung KS
    J Reprod Fertil Suppl; 1996; 50():159-63. PubMed ID: 8984179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and contraceptive efficacy of Escherichia coli-expressed recombinant porcine zona pellucida proteins.
    Gupta N; Chakrabarti K; Prakash K; Wadhwa N; Gupta T; Gupta SK
    Am J Reprod Immunol; 2013 Aug; 70(2):139-52. PubMed ID: 23444974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of zona pellucida antigens as potential candidates for immunocontraception.
    Paterson M; Wilson MR; van Duin M; Aitken RJ
    J Reprod Fertil Suppl; 1996; 50():175-82. PubMed ID: 8984181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology approaches to evaluate species variation in immunogenicity and antigenicity of zona pellucida proteins.
    Prasad SV; Wilkins B; Dunbar BS
    J Reprod Fertil Suppl; 1996; 50():143-9. PubMed ID: 8984177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine zona pellucida glycoprotein-3: up-scaled production, immunization strategy and its outcome on fertility.
    Shrestha A; Srichandan S; Minhas V; Panda AK; Gupta SK
    Vaccine; 2015 Jan; 33(1):133-40. PubMed ID: 25448113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibody immunoreactivity to equine zona protein after SpayVac vaccination.
    Mask TA; Schoenecker KA; Kane AJ; Ransom JI; Bruemmer JE
    Theriogenology; 2015 Jul; 84(2):261-7. PubMed ID: 25922172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-zona pellucida monoclonal antibodies on fertilization and early development.
    Dean J; East IJ
    Adv Exp Med Biol; 1986; 207():37-53. PubMed ID: 3825684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of zona pellucida vaccines.
    Ndolo TM; Oguna M; Bambra CS; Dunbar BS; Schwoebel ED
    J Reprod Fertil Suppl; 1996; 50():151-8. PubMed ID: 8984178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of a conserved B cell epitope on bonnet monkey (Macaca radiata) and human zona pellucida glycoprotein-B by monoclonal antibodies demonstrating inhibition of sperm-egg binding.
    Govind CK; Hasegawa A; Koyama K; Gupta SK
    Biol Reprod; 2000 Jan; 62(1):67-75. PubMed ID: 10611069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular approaches for the evaluation of immune responses to zona pellucida (ZP) and development of second-generation ZP vaccines.
    Dunbar BS; Kaul G; Prasad M; Skinner SM
    Reprod Suppl; 2002; 60():9-18. PubMed ID: 12220169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antibodies against a chimeric synthetic peptide encompassing epitopes of bonnet monkey (Macaca radiata) zona pellucida-1 and zona pellucida-3 glycoproteins to inhibit in vitro human sperm-egg binding.
    Sivapurapu N; Hasegawa A; Gahlay GK; Koyama K; Gupta SK
    Mol Reprod Dev; 2005 Mar; 70(3):247-54. PubMed ID: 15625695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.